Neuroscience: The compound is explored for its neuroprotective properties, aiding in the investigation of neurodegenerative diseases and potential therapeutic strategies
The success of oral semaglutide and the wider oral GLP-1 pipeline shows that more complex therapies can move into solid oral dosage forms
Best dose gave 44% response / 32% remission vs 32% / 20% for placebo described by the authors as numerically higher, i.e
In preclinical and in vitro studies, the three components are being researched in relation to tissue repair and skin-related processes: BPC-157 in connection with the formation of new blood vessels and tissue regeneration, TB-500 in connection with cell migration, and GHK-Cu in connection with collagen formation and skin structure
The Wolverine Stack Done Right: Why Clinical Oversight Matters for BPC-157 and TB-500 If youve heard about concierge medicine and want to know more about this type of health care, we take a closer look.
But heres the plot twist: your body already knows how to make GLP-1 on its own